UROLOGIC CANCER
Clinical trials for UROLOGIC CANCER explained in plain language.
Never miss a new study
Get alerted when new UROLOGIC CANCER trials appear
Sign up with your email to follow new studies for UROLOGIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New bladder cancer drug could spare patients from losing their bladder
Disease control Not yet recruitingThis phase 3 study tests a new drug called NDV-01 for people with non-muscle invasive bladder cancer. The drug is given directly into the bladder to help prevent the cancer from coming back or getting worse. The study includes two groups: one with intermediate-risk cancer compari…
Matched conditions: UROLOGIC CANCER
Phase: PHASE3 • Sponsor: Relmada Therapeutics, Inc. • Aim: Disease control
Last updated May 04, 2026 16:30 UTC
-
MRI may spot hidden urinary tract cancers without needles
Diagnosis Not yet recruitingThis study looks at whether a special MRI scan can accurately detect invasive tumors in the upper urinary tract. About 178 adults with suspicious findings on a CT scan will receive an MRI, and the results will be compared to standard biopsy or follow-up CT. If successful, MRI cou…
Matched conditions: UROLOGIC CANCER
Phase: NA • Sponsor: University Hospital, Toulouse • Aim: Diagnosis
Last updated May 15, 2026 11:55 UTC
-
New program aims to ease pain after pelvic radiation
Symptom relief Not yet recruitingThis study tests a support program to help women who have had pelvic radiation therapy use vaginal dilators more regularly. Dilators can prevent or treat vaginal narrowing that causes pain during exams or sex. About 88 women will be split into two groups: one gets the new program…
Matched conditions: UROLOGIC CANCER
Phase: NA • Sponsor: Duke University • Aim: Symptom relief
Last updated May 05, 2026 11:53 UTC